The company will address the observations within the stipulated timeline.
Dr. Reddy’s facility in Andhra Pradesh gets 2 U.S. FDA observations
Published ·

Keep reading
Related stories


Published ·

The company will address the observations within the stipulated timeline.
Keep reading

